Membership Directory
Affimed GmbH
- Bioscience
-
About
Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK- and T-cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases.
-
Whom to Contact
- Dr. Florian FischerChief Financial OfficerPhone: +49 6221 6743664Fax: +49 6221 6530749
-
-